LXEO Operating Cash Flow Growth

Lexeo Therapeutics Inc · Operating Cash Flow Growth

LXEO logo

LXEO Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported7.05%
LXEO TTM Cash from Operations YoY % (-9.04% → 7.05%)
High-resolution chart · PNG

LXEO operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Lexeo Therapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
7.0477%
-11.3511%
-21.4538%
-59.8779%
-51.0223%
-57.1773%
-36.4003%
-7.5093%
-4.9505%
3.2011%
-9.0446%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.